Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study

Discussing edaravone with the ALS patient: an ethical framework from a U.S. perspective

(2018) Crystal Jing Jing Yeo et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

(2017) Koji Abe et al.   LANCET NEUROLOGY

Pterostilbene Decreases the Antioxidant Defenses of Aggressive Cancer Cells In Vivo: A Physiological Glucocorticoids- and Nrf2-Dependent Mechanism

(2016) María Benlloch et al.   ANTIOXIDANTS & REDOX SIGNALING

SIRT1 activation by pterostilbene attenuates the skeletal muscle oxidative stress injury and mitochondrial dysfunction induced by ischemia reperfusion injury

(2016) Yedong Cheng et al.   APOPTOSIS

Neuroprotective effects of pterostilbene against oxidative stress injury: Involvement of nuclear factor erythroid 2-related factor 2 pathway

(2016) Bodong Wang et al.   BRAIN RESEARCH

NAD + Replenishment Improves Lifespan and Healthspan in Ataxia Telangiectasia Models via Mitophagy and DNA Repair

(2016) Evandro Fei Fang et al.   Cell Metabolism

Could Sirtuin Activities Modify ALS Onset and Progression?

(2016) Bor Luen Tang   CELLULAR AND MOLECULAR NEUROBIOLOGY

Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes

(2016) Yan Guo et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Correlation between Forced Vital Capacity and Slow Vital Capacity for the assessment of respiratory involvement in Amyotrophic Lateral Sclerosis: a prospective study

(2016) Susana Pinto et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

SARM1 activation triggers axon degeneration locally via NAD+ destruction

(2015) J. Gerdts et al.   SCIENCE

Definition of the Mediterranean Diet; A Literature Review

(2015) Courtney Davis et al.   Nutrients

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial

(2014) Merit E Cudkowicz et al.   LANCET NEUROLOGY

Pharmacokinetics and tissue distribution of pterostilbene in the rat

(2014) Michele Azzolini et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Espirometría

(2013) Francisco García-Río et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs

(2013) Takumi Satoh et al.   FREE RADICAL BIOLOGY AND MEDICINE

Calorie restriction and sirtuins revisited

(2013) L. Guarente   GENES & DEVELOPMENT

Mitochondrial Glutathione Transport Is a Key Determinant of Neuronal Susceptibility to Oxidative and Nitrosative Stress

(2013) Heather M. Wilkins et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice

(2012) Soyoung Han et al.   BRAIN RESEARCH

The Role of PARP-1 and PARP-2 Enzymes in Metabolic Regulation and Disease

(2012) Péter Bai et al.   Cell Metabolism

Differential Sirtuin Expression Patterns in Amyotrophic Lateral Sclerosis (ALS) Postmortem Tissue: Neuroprotective or Neurotoxic Properties of Sirtuins in ALS?

(2012) Sonja Körner et al.   Neurodegenerative Diseases

Clinical significance in the change of decline in ALSFRS-R

(2010) Carmen Castrillo-Viguera et al.   Amyotrophic Lateral Sclerosis

Calorie Restriction Reduces Oxidative Stress by SIRT3-Mediated SOD2 Activation

(2010) Xiaolei Qiu et al.   Cell Metabolism

ALSFRS-R score and its ratio: A useful predictor for ALS-progression

(2008) Katja Kollewe et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES